Ftse Mib
34.135,63
-0,07%
DAX
19.939,09
-0,10%
S&P 500
5.970,84
-1,11%
NASDAQ
19.722,03
-1,49%
Bitcoin
93.688,38
0,18%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AC Immune SA (ACIU) AC Immune SA (ACIU) Notizie

AC Immune SA

ACIU
2,73
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202423:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202423:15EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
10/12/202414:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/12/202413:00GLOBEAC Immune Reports Interim Safety Data from Phase 1b/2 ABATE..
14/11/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202413:00GLOBEAC Immune Reports Positive Interim Results from Phase 2..
13/11/202413:00GLOBEAC Immune to Present at the Jefferies 2024 London Healthcare..
05/11/202413:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/11/202413:00GLOBEAC Immune Reports Third Quarter 2024 Financial Results and..
27/9/202422:26EDGAR2Form 144 - Report of proposed sale of securities
19/9/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/9/202422:40EDGAR2Form 144 - Report of proposed sale of securities
17/9/202413:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202415:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/8/202422:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/8/202422:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/8/202413:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
31/7/202414:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/7/202422:53EDGAR2Form F-3/A - Registration statement by foreign private..
25/7/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/5/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/5/202420:23EDGAR2Form 144 - Report of proposed sale of securities
13/5/202412:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/5/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/2/202422:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/1/202413:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202422:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/1/202414:10GLOBEAC Immune Progress Update on Phase 2 Active Immunotherapy..
Apertura: Min: Max:
Chiusura: 2,73

La tua Cronologia

NASDAQ
ACIU
AC Immune
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network